Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EBT: 2020-2025

Historic EBT for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to -$2.8 million.

  • iSpecimen's EBT fell 65.34% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.3 million, marking a year-over-year decrease of 26.75%. This contributed to the annual value of -$12.9 million for FY2024, which is 18.55% down from last year.
  • Per iSpecimen's latest filing, its EBT stood at -$2.8 million for Q3 2025, which was down 55.40% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's EBT ranged from a high of -$1.6 million in Q3 2021 and a low of -$6.0 million during Q4 2024.
  • Over the past 3 years, iSpecimen's median EBT value was -$2.4 million (recorded in 2023), while the average stood at -$2.7 million.
  • Per our database at Business Quant, iSpecimen's EBT tumbled by 141.97% in 2021 and then soared by 44.95% in 2025.
  • Quarterly analysis of 5 years shows iSpecimen's EBT stood at -$2.0 million in 2021, then decreased by 6.51% to -$2.2 million in 2022, then slumped by 30.96% to -$2.8 million in 2023, then crashed by 111.96% to -$6.0 million in 2024, then tumbled by 65.34% to -$2.8 million in 2025.
  • Its last three reported values are -$2.8 million in Q3 2025, -$1.8 million for Q2 2025, and -$1.6 million during Q1 2025.